ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2016

Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years.

Nandu Thalange et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.